Small intracerebral haemorrhages are associated with less haematoma expansion and better outcomes

International Journal of Stroke

Volumn 6, Issue 3, 2011, Pages 201-206

  Dowlatshahi, Dar ^a   Smith, Eric E ^b   Flaherty, Matthew L ^c   Ali, Myzoon ^d   Lyden, Patrick ^e   Demchuk, Andrew M ^b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d Gardiner Institute   (United Kingdom)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Clinical trial; Cohort; Haematoma expansion; Intracerebral haemorrhage; Natural history; Outcomes; Prognosis; VISTA

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

AGED; ARTICLE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; SYMPTOM;

AGED; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GLASGOW COMA SCALE; HEMATOMA; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79955783623     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00563.x     Document Type: Article

References (27)

1. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 1996; 27:1783-7.
2. Davis SM, Broderick J, Hennerici M et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006; 66:1175-81.
3. Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997; 28:2370-5.
4. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24:987-93.
5. Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001; 32:891-7.
6. Rost NS, Smith EE, Chang Y et al. Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke 2008; 39:2304-9.
7. Broderick JP, Diringer MN, Hill MD et al. Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke 2007; 38:1072-5.
8. Barras CD, Tress BM, Christensen S et al. Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke 2009; 40:1325-31.
9. Mayer SA, Brun NC, Begtrup K et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352:777-85.
10. Mayer SA, Brun NC, Begtrup K et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008; 358:2127-37.
11. Anderson CS, Huang Y, Wang JG et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008; 7:391-9.
12. Goldstein JN, Fazen LE, Snider R et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology 2007; 68:889-94.
13. Wada R, Aviv RI, Fox AJ et al. CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke 2007; 38:1257-62.
14. Mayer SA, Davis SM, Skolnick BE et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke 2009; 40:833-40.
15. Cho DY, Chen CC, Lee HC, Lee WY, Lin HL. Glasgow coma scale and hematoma volume as criteria for treatment of putaminal and thalamic intracerebral hemorrhage. Surg Neurol 2008; 70:628-33.
16. Demchuk AM, Alzawahmah M, Kosior J et al. Multicentre prospective study demonstrates validity of CTA spot sign for hematoma expansion prediction in noncoagulopathic primary ICH patients (abstract). Cerebrovasc Dis 2008; 25 (Suppl. 2): 52.
17. Ali M, Bath PM, Curram J et al. The Virtual International Stroke Trials Archive. Stroke 2007; 38:1905-10.
18. The spot sign for predicting and treating ICH growth study, 2010. Available at (NCT00810888).
19. Mayer SA, Brun NC, Broderick J et al. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 2005; 36:74-9.
20. Brott T, Broderick J, Kothari R et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28:1-5.
21. Steiner T, Diringer MN, Schneider D et al. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery 2006; 59:767-73.
22. Cucchiara B, Messe S, Sansing L, Kasner S, Lyden P, CHANT Investigators. Hematoma growth in oral anticoagulant related intracerebral hemorrhage. Stroke 2008; 39:2993-6.
23. Fisher CM. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol 1971; 30:536-50.
24. Mayer SA, Lignelli A, Fink ME et al. Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study. Stroke 1998; 29:1791-8.
25. Lisk DR, Pasteur W, Rhoades H, Putnam RD, Grotta JC. Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation. Neurology 1994; 44:133-9.
26. Flaherty ML, Woo D, Haverbusch M et al. Racial variations in location and risk of intracerebral hemorrhage. Stroke 2005; 36:934-7.
27. Zahuranec DB, Gonzales NR, Brown DL et al. Presentation of intracerebral haemorrhage in a community. J Neurol Neurosurg Psychiatry 2006; 77:340-4.